Back to Authors

Patel, Shardool A.

0000-0002-0274-8800

A5045097402 | I4210147126

Mayo Clinic

Liquidia Technologies (United States)

Citations 2

A Phase 3, 2-part, Open-label, Multicenter Study to Evaluate the Safety, and Efficacy of Liposomal Treprostinil Inhalation Suspension (l606) in Subjects With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung

D105. BALBOA PARK EXPLORERS: TRANSLATIONAL SCIENCE AND EPIDEMIOLOGY IN PH | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A7368-A7368

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7368

Exploratory Efficacy Analysis of INSPIRE Open Label Extension Study With Inhaled Treprostinil (Yutrepia™)

B64. THE MULTIPLE COMPONENTS OF PULMONARY REHABILITATION | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A3928-A3928

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3928